Makary Resigns as FDA Commissioner Following Policy Disputes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

  • 1

    Marty Makary resigned as FDA Commissioner after 13 months, with Kyle Diamantas appointed as acting commissioner.

  • 2

    Makary's tenure included workforce reductions and significant turnover among senior FDA officials.

  • 3

    He opposed pediatric mask and vaccine mandates during the COVID-19 pandemic, criticizing CDC data reliance.

  • 4

    Makary focused on vaccine policy, food additive regulation, and dietary guidance, advocating for reduced processed food intake.

  • 5

    His resignation followed tensions over telehealth prescribing, regulatory review consistency, and flavored vaping product authorizations.

Original Source(s)

Makary Resigns as FDA Commissioner Following Policy Disputes

  • by Kathryn Wighton

  • May 12, 2026

Related Content

Tele-guided lung ultrasound may be acceptable to paramedics

Trainees rated remote-guided imaging favorably, while technical reliability and communication emerged as barriers to implementation.

TOFA may drive weight loss without reducing food intake

The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.